Mosaic Diagnostics

10/15/2026

What if the answers to your health concerns start at home?

“Mold is a serious and underrecognized health concern.” - HHS Secretary at the Mold Roundtable, October 9, 2026

That's why Mosaic Diagnostics partnered with The Dust Test to launch MycoTOX Body + Home, connecting insights about mold in the home with mycotoxin testing in the body.

Two perspectives. One more complete picture of potential exposure. .

Source: https://www.youtube.com/watch?v=BJPHVudX79Q

10/15/2026

Understanding mycotoxin exposure begins with accurate testing.

The MycoTOX Profile measures 11 clinically relevant mycotoxins using advanced LC-MS/MS technology, helping practitioners evaluate potential mold exposure with precision and confidence.
Support more targeted, data-informed care.

Learn more about the MycoTOX Profile:
mosaicdx.com/test/mycotox-profile/

10/13/2026

The Organic Acids Test (OAT) has helped practitioners evaluate metabolic health for decades through one comprehensive assessment.

By measuring 76 organic acids, the OAT provides insight into mitochondrial function, nutrient status, detoxification, oxidative stress, neurotransmitter metabolism, microbial activity, and more which helps uncover the biochemical factors that may contribute to complex clinical presentations.

Support more targeted, data-informed care.

Learn more about the Organic Acids Test:
mosaicdx.com/test/organic-acids-test/

10/06/2026

Join us for an upcoming live webinar, “When the Microbiome Shrinks: Organic Acids, Neurotransmitters, and Depression,” featuring Dr. Andrew Rostenberg, D.C., DIBAK.

Explore the connections between the gut microbiome, organic acids, neurotransmitter pathways, and mental health, and gain insights to help inform a more comprehensive approach to patient care.

📅 October 27
⏰ 3–4 PM ET

Save your spot and learn more: https://us06web.zoom.us/webinar/register/WN_4fLMC5nSQj-jfggBDi7XMQ #/registration

10/05/2026

We’re proud to sponsor the 2026 Midwest Functional Medicine Symposium!

Join us on October 10 for the Midwest Functional Medicine Symposium, presented by Forum Health in partnership with Power2Practice.

Stop by Booth 13 to connect with the Mosaic Diagnostics team, learn more about our testing, and get your questions answered.

If you’re attending, come say hello. We look forward to seeing you there!

10/02/2026

Go beyond SNPs with DNA Signature.

DNA Signature is a next-generation suite of genomic profiles that incorporates Polygenic Risk Scoring (PRS) to evaluate the combined influence of multiple genetic variants across key biological pathways.

Swipe through to explore all five profiles:
Metabolic Path, Toxins, Mind & Mood, Spectrum Map, and Wellness.

Each profile is designed to provide deeper genetic insight and help support a more personalized path forward.

Learn more about the full DNA Signature suite:
mosaicdx.com/test/dna-signature-suite-of-tests/

09/24/2026

Going Beyond SNPs. Polygenic Risk Scoring for a More Personalized Path Forward.

DNA Signature combines Polygenic Risk Scoring (PRS) with easy-to-understand results and prioritized guidance—helping practitioners move from complex genetic information to insights they can use.

With carefully curated traits and SNPs across five genomic profiles, DNA Signature provides targeted guidance on diet and supplements, lifestyle and exercise, and functional testing.

Explore DNA Signature and learn more about the five genomic profiles: https://mosaicdx.com/test/dna-signature-suite-of-tests/

09/23/2026

Like HHS, EPA and the clinicians we support across the Globe, we care about environmental exposures.

HHS and EPA just announced a new scientific partnership to strengthen the ongoing review of glyphosate, including research into human exposure, biomonitoring and potential health effects.

At Mosaic Diagnostics, we’re helping practitioners look beyond symptoms and investigate potential environmental exposures, including glyphosate.

Because Better Health Starts with Better Answers.

👉 Read the HHS announcement: https://www.hhs.gov/press-room/hhs-epa-partnership-strengthen-glyphosate-review.html

HHS and EPA launch a scientific partnership to strengthen research and support EPA’s ongoing glyphosate registration review under FIFRA.

09/23/2026

DNA SIGNATURE is here. Now, take a closer look at how DNA testing can help inform more personalized patient care. 🧬

Join Michelle Maddux, ND, Director of Clinical Education at MosaicDx, and Scott Mattivi, CEO of Mosaic Diagnostics, for a live webinar exploring how smarter genetic insights can help accelerate a more personalized approach to patient care.

📅 September 30
⏰ 3–4 PM ET

Smarter Insights, Better Outcomes: Using DNA Testing to Accelerate Personalized Patient Care

Register now to join us: https://mosaicdx.com/resource/smarter-insights-better-outcomes-using-snp-testing-to-accelerate-personalized-patient-care/

09/16/2026

DNA SIGNATURE is here. Now, take a closer look at how DNA testing can help inform more personalized patient care. 🧬

Join Michelle Maddux, ND, Clinical Educator at MosaicDx, and Scott Mattivi, CEO of Mosaic Diagnostics, for a live webinar exploring how smarter genetic insights can help accelerate a more personalized approach to patient care.

📅 September 30
⏰ 3–4 PM ET

Smarter Insights, Better Outcomes: Using DNA Testing to Accelerate Personalized Patient Care

Register now to join us live: https://mosaicdx.com/resource/smarter-insights-better-outcomes-using-snp-testing-to-accelerate-personalized-patient-care/